Diclofenac Sodium And Misoprostol Tablet, Delayed Release
FDA Label NDC 71335-1183

43 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Diclofenac Sodium And Misoprostol (NDC 71335-1183). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: risk of uterine rupture, abortion, premature birth, birth defects; serious cardiovascular events; and serious gastrointestinal events, 1 indications and usage, 2.1 important dosage information, 2.2 recommended dosage in patients with osteoarthritis, 2.3 recommended dosage in patients with rheumatoid arthritis, 2.4 additional dosage recommendations, 3 dosage forms and strengths, 4 contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Diclofenac Sodium And Misoprostol Delayed-Release Tablets 75 Mg/200 Mcg

Label (Lbl713351183)

Label (Lbl713351183)

* Please review the disclaimer below.